Marie Lamberigts, Bert Sarrazin, Delphine Szecel, Filip Rega, Peter Verbrugghe, Christophe Dubois, Bart Meuris
{"title":"无缝合与经导管主动脉瓣置换术:倾向匹配分析。","authors":"Marie Lamberigts, Bert Sarrazin, Delphine Szecel, Filip Rega, Peter Verbrugghe, Christophe Dubois, Bart Meuris","doi":"10.1080/17434440.2025.2563619","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The goal of this study is to perform a propensity score matched analysis of sutureless AVR and TAVR to compare patient characteristics and postoperative outcomes including hemodynamic performance.</p><p><strong>Methods: </strong>Patients treated with either sutureless aortic valve replacement (SU-AVR) using Perceval<sup>TM</sup> or transcatheter aortic valve replacement between October 2017 and June 2022 were included. Propensity score matching (PSM) was used to limit the bias in a non-randomized study.</p><p><strong>Results: </strong>After PSM, 118 pairs of patients were obtained. The in-hospital mortality rate was 0% in SU-AVR and 4.2% in TAVR (<i>p</i> = 0.063). Postoperative complication rates including disabling stroke (0% vs 2.5%, <i>p</i> = 0.250), new need for dialysis (1.7% vs 0%, <i>p</i> = 0.500), and permanent pacemaker implantation at 30 days (5.9% vs 10.2%, <i>p</i> = 0.332) showed no statistical difference. At discharge, TAVR showed significantly lower peak and mean gradients, while paravalvular leakage higher than 1/4 was significantly higher in TAVR (11% vs 0%, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>TAVR offers significantly better transprosthetic gradients, shorter ICU and hospital stays, and less need for postoperative dialysis. Surgery using a sutureless valve showed less paravalvular leakage.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"1-8"},"PeriodicalIF":2.7000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sutureless versus transcatheter aortic valve replacement: propensity matched analysis.\",\"authors\":\"Marie Lamberigts, Bert Sarrazin, Delphine Szecel, Filip Rega, Peter Verbrugghe, Christophe Dubois, Bart Meuris\",\"doi\":\"10.1080/17434440.2025.2563619\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The goal of this study is to perform a propensity score matched analysis of sutureless AVR and TAVR to compare patient characteristics and postoperative outcomes including hemodynamic performance.</p><p><strong>Methods: </strong>Patients treated with either sutureless aortic valve replacement (SU-AVR) using Perceval<sup>TM</sup> or transcatheter aortic valve replacement between October 2017 and June 2022 were included. Propensity score matching (PSM) was used to limit the bias in a non-randomized study.</p><p><strong>Results: </strong>After PSM, 118 pairs of patients were obtained. The in-hospital mortality rate was 0% in SU-AVR and 4.2% in TAVR (<i>p</i> = 0.063). Postoperative complication rates including disabling stroke (0% vs 2.5%, <i>p</i> = 0.250), new need for dialysis (1.7% vs 0%, <i>p</i> = 0.500), and permanent pacemaker implantation at 30 days (5.9% vs 10.2%, <i>p</i> = 0.332) showed no statistical difference. At discharge, TAVR showed significantly lower peak and mean gradients, while paravalvular leakage higher than 1/4 was significantly higher in TAVR (11% vs 0%, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>TAVR offers significantly better transprosthetic gradients, shorter ICU and hospital stays, and less need for postoperative dialysis. Surgery using a sutureless valve showed less paravalvular leakage.</p>\",\"PeriodicalId\":94006,\"journal\":{\"name\":\"Expert review of medical devices\",\"volume\":\" \",\"pages\":\"1-8\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert review of medical devices\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17434440.2025.2563619\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of medical devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17434440.2025.2563619","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:本研究的目的是对无缝线AVR和TAVR进行倾向评分匹配分析,以比较患者特征和术后结果,包括血流动力学表现。方法:纳入2017年10月至2022年6月期间使用PercevalTM进行无缝线主动脉瓣置换术(SU-AVR)或经导管主动脉瓣置换术的患者。倾向评分匹配(PSM)用于限制非随机研究的偏倚。结果:经PSM治疗,获得118对患者。SU-AVR组住院死亡率为0%,TAVR组为4.2% (p = 0.063)。术后并发症发生率包括致残性卒中(0% vs 2.5%, p = 0.250)、新需要透析(1.7% vs 0%, p = 0.500)和30天永久性起搏器植入(5.9% vs 10.2%, p = 0.332),差异无统计学意义。出院时,TAVR的峰值和平均梯度明显降低,而高于1/4的瓣旁漏明显高于TAVR (11% vs 0%, p)。结论:TAVR具有明显更好的经假体梯度,缩短ICU和住院时间,减少术后透析需求。无缝合线瓣膜手术显示瓣旁渗漏较少。
Sutureless versus transcatheter aortic valve replacement: propensity matched analysis.
Background: The goal of this study is to perform a propensity score matched analysis of sutureless AVR and TAVR to compare patient characteristics and postoperative outcomes including hemodynamic performance.
Methods: Patients treated with either sutureless aortic valve replacement (SU-AVR) using PercevalTM or transcatheter aortic valve replacement between October 2017 and June 2022 were included. Propensity score matching (PSM) was used to limit the bias in a non-randomized study.
Results: After PSM, 118 pairs of patients were obtained. The in-hospital mortality rate was 0% in SU-AVR and 4.2% in TAVR (p = 0.063). Postoperative complication rates including disabling stroke (0% vs 2.5%, p = 0.250), new need for dialysis (1.7% vs 0%, p = 0.500), and permanent pacemaker implantation at 30 days (5.9% vs 10.2%, p = 0.332) showed no statistical difference. At discharge, TAVR showed significantly lower peak and mean gradients, while paravalvular leakage higher than 1/4 was significantly higher in TAVR (11% vs 0%, p < 0.001).
Conclusions: TAVR offers significantly better transprosthetic gradients, shorter ICU and hospital stays, and less need for postoperative dialysis. Surgery using a sutureless valve showed less paravalvular leakage.